RESUMEN

BACKGROUND: In very low birth weight (VLBW) infants, obstructive bronchitis is a frequent cause of hospital re-admission. For VLBW infants, early vaccinations starting at 2 months after birth have been recommended. OBJECTIVE: To analyze risk factors for bronchitis during the first year after discharge and the effects of in-hospital standard vaccination (hexavalent/pneumococci) and/or RSV immunoprophylaxis with palivizumab. METHODS: A standardized questionnaire was sent to the parents of VLBW infants 7 month after discharge. The reported episodes of bronchitis were correlated with clinically recorded parameters including risk factors for pulmonary morbidity. The effects of in-hospital vaccination were assessed in a subgroup discharged after day 60. RESULTS: A sample of 1 967 responses of infants born 2009-2011 was analyzed. Risk factors for bronchitis were male gender and older siblings. 24% of the population had episodes of bronchitis. In the subgroup discharged after day 60, episodes of bronchitis were reported for 31% of infants who were not vaccinated in-hospital. A significant reduction of the bronchitis rate was found in infants who received palivizumab±standard vaccination (17% bronchitis, p=0.003). Interestingly, in-hospital standard vaccination without RSV immunoprophylaxis was protective (20% bronchitis; p=0.037) as well. CONCLUSIONS: Non-vaccinated male VLBW infants with older siblings are at increased risk for bronchitis during the first year after discharge. Vaccination according to schedule seems to have protective effects, while underlying mechanisms are unknown. The rate of timely vaccination in preterm infants should be increased.

Asunto(s)

Bronquitis/etiología , Bronquitis/prevención & control , Enfermedades del Prematuro/etiología , Enfermedades del Prematuro/prevención & control , Recién Nacido de muy Bajo Peso , Alta del Paciente , Infecciones por Virus Sincitial Respiratorio/etiología , Infecciones por Virus Sincitial Respiratorio/prevención & control , Vacunas contra Virus Sincitial Respiratorio/administración & dosificación , Estudios de Cohortes , Terapia Combinada , Femenino , Estudios de Seguimiento , Alemania , Humanos , Lactante , Recién Nacido , Enfermedades del Prematuro/mortalidad , Masculino , Palivizumab/administración & dosificación , Infecciones por Virus Sincitial Respiratorio/mortalidad , Factores de Riesgo , Encuestas y Cuestionarios , Análisis de Supervivencia

Asunto(s)

Enterocolitis Necrotizante/diagnóstico , Enfermedades del Prematuro/diagnóstico , Leucocitosis/diagnóstico , Tos Ferina/diagnóstico , Abdomen Agudo/diagnóstico , Abdomen Agudo/patología , Abdomen Agudo/prevención & control , Diagnóstico Diferencial , Enterocolitis Necrotizante/patología , Enterocolitis Necrotizante/prevención & control , Resultado Fatal , Femenino , Humanos , Lactante , Recién Nacido , Enfermedades del Prematuro/patología , Enfermedades del Prematuro/prevención & control , Intestinos/irrigación sanguínea , Isquemia/diagnóstico , Isquemia/patología , Isquemia/prevención & control , Leucocitosis/patología , Leucocitosis/prevención & control , Atelectasia Pulmonar/diagnóstico , Atelectasia Pulmonar/patología , Atelectasia Pulmonar/prevención & control , Insuficiencia Respiratoria/diagnóstico , Insuficiencia Respiratoria/patología , Insuficiencia Respiratoria/prevención & control , Choque Séptico/diagnóstico , Choque Séptico/patología , Choque Séptico/prevención & control , Tos Ferina/patología , Tos Ferina/prevención & control

RESUMEN

The German Neonatal Network (GNN) is a prospective cohort study with the focus on long term development of very-low-birth-weight infants. It was the aim of this study to determine detailed information on causes of mortality in the GNN birth cohort 2010.Major contributors to hospital mortality were recorded by the attending neonatologists for the cohort of very-low-birth-weight (VLBW) infants born in centres of the German Neonatal Network (GNN) in 2010. The data quality was approved by on-site monitoring.2 221 VLBW infants were born in GNN centres in 2010, and death occurred in 221 infants. Male infants carried a higher risk than females (58.8% males among non-survivors vs. 51.7% among survivors, p=0.047). In 11 infants, the major contributor to death was not determined by the attending neonatologist. In 25 infants born at the limit of viability, comfort palliative care was primarily initiated and 14 infants had lethal malformations. The majority of non-survivors suffered from inflammatory diseases including sepsis- or necrotizing enterocolitis (NEC)-associated death (n=56). Respiratory pathology was a major contributor to death in 65 infants including 11 infants who died from pulmonary haemorrhage.Potentially preventable complications of preterm birth such as sepsis, NEC and pulmonary haemorrhage predominate the major contributors to mortality in the GNN 2010 cohort. In order to decrease the rate of these associated deaths, future trials should focus on prophylaxis and therapy optimization strategies for these outcomes.

Asunto(s)

Causas de Muerte , Mortalidad Hospitalaria , Enfermedades del Prematuro/mortalidad , Recién Nacido de muy Bajo Peso , Estudios de Cohortes , Enterocolitis Necrotizante/mortalidad , Femenino , Alemania , Hemorragia/mortalidad , Humanos , Recién Nacido , Enfermedades Pulmonares/mortalidad , Masculino , Estudios Prospectivos , Síndrome de Dificultad Respiratoria del Recién Nacido/mortalidad , Factores de Riesgo , Sepsis/mortalidad , Factores Sexuales

RESUMEN

BACKGROUND: Recently in a report of a single center a method has been described to apply surfactant via a thin endotracheal catheter to very low birth weight infants spontaneously breathing with nasal continuous positive airway pressure. We now analyzed available multicenter data. PATIENTS AND METHODS: In a multicenter study investigating genetic risk factors, clinical and outcome data and data of antenatal and postnatal treatment of infants with a birth weight below 1,500 g were prospectively recorded. The measures of infants treated with the new method of surfactant application were compared to those of infants who received standard care. The analysis was restricted to infants with a gestational age below 31 weeks (n=1,541). RESULTS: 319 infants were treated with the new method and 1,222 with standard care. The need for mechanical ventilation during the first 72 h (29% vs. 53%, p<0.001), the rate of bronchopulmonary dysplasia defined as oxygen at 36 weeks of postmenstrual age (10.9 % vs. 17.5%, p=0.004) and the rate of death or bronchopulmonary dysplasia were significantly lower in the treatment group than in the standard care group. Surfactant, theophyllin, caffeine and doxapram were significantly more often and analgetics, catecholamines and dexamethasone were significantly less frequently used in the treatment group. CONCLUSIONS: A new method of surfactant application was associated with a lower prevalence of mechanical ventilation and better pulmonary outcome. A prospective controlled trial is required to determine whether this approach is superior to standard care.

Asunto(s)

Recien Nacido con Peso al Nacer Extremadamente Bajo , Recién Nacido de muy Bajo Peso , Intubación Intratraqueal/instrumentación , Surfactantes Pulmonares/administración & dosificación , Síndrome de Dificultad Respiratoria del Recién Nacido/tratamiento farmacológico , Productos Biológicos/administración & dosificación , Displasia Broncopulmonar/mortalidad , Displasia Broncopulmonar/prevención & control , Estudios de Cohortes , Presión de las Vías Aéreas Positiva Contínua , Femenino , Edad Gestacional , Humanos , Recién Nacido , Instilación de Medicamentos , Masculino , Terapia por Inhalación de Oxígeno , Fosfolípidos/administración & dosificación , Estudios Prospectivos , Síndrome de Dificultad Respiratoria del Recién Nacido/mortalidad , Análisis de Supervivencia

RESUMEN

BACKGROUND: The insertion/deletion polymorphism of the angiotensin-converting enzyme (ACE-ins/del) and the angiotensin II type 1 receptor 1166A/C polymorphism (ATR1166A/C) were reported to be associated with several unfavorable outcome parameters in preterm infants like bronchopulmonary dysplasia, persistent ductus arteriosus and impaired insulin sensitivity. OBJECTIVE: To confirm the above-mentioned associations in a large cohort of very-low-birthweight (VLBW) infants. METHOD: Clinical data of VLBW infants were prospectively recorded. The ACE-ins/del polymorphism and the ATR1166A/C polymorphism were determined by polymerase chain reaction in 1,209 and 1,168 infants, respectively. RESULTS: There was no significant association between ACE-ins/del or ATR1166A/C genotype and outcome parameters (death, intraventricular hemorrhage, sepsis, bronchopulmonary dysplasia, ventilation, supplemental oxygen at discharge, postnatal treatment with insulin, surgery for intestinal perforation/necrotizing enterocolitis/retinopathy of prematurity/persistent ductus arteriosus. CONCLUSION: Both known functional polymorphisms of the renin-angiotensin system do not seem to be associated with the outcome of VLBW infants.

Asunto(s)

Predisposición Genética a la Enfermedad/genética , Enfermedades del Prematuro/genética , Recién Nacido de muy Bajo Peso/fisiología , Polimorfismo de Nucleótido Simple , Sistema Renina-Angiotensina/genética , Adulto , Estudios de Cohortes , Femenino , Predisposición Genética a la Enfermedad/epidemiología , Pruebas Genéticas , Humanos , Lactante , Recién Nacido , Enfermedades del Prematuro/epidemiología , Masculino , Embarazo , Resultado del Embarazo , Estudios Prospectivos

RESUMEN

We investigated the association between the interleukin 6 (IL-6)-174-genotype and unfavorable outcomes in preterm infants since it has been reported that the IL-6-174GG-genotype is associated with increased susceptibility to sepsis, and the IL-6-174CC-genotype is more common in preterm infants with severe intraventricular hemorrhage (IVH). We studied 1206 preterm infants with a birth weight below 1500 g. In contrast to previously published data, the frequency of IVH grade IV, periventricular leukomalacia, ventricular-peritoneal-shunting or death was not different between infants with different IL-6-genotypes: IL-6-174GG (n = 430) 8%, IL-6-174GC (n = 605) 9% and IL-6-174CC (n = 167) 12% (P = 0.2 for IL-6-174CC vs GG + GC). Furthermore, we were not able to confirm previously reported association between sepsis and the IL-6-174GG-genotype. Blood-culture-proven sepsis occurred in 19% of IL-6-174GG-carriers (n = 157), 26% of IL-6-174GC-carriers (n = 193) and 27% of infants carrying the IL-6-174CC-genotype (n = 67). We were not able to confirm previously reported associations between sepsis, cerebral injury and the IL-6-174-genotype in VLBW-infants.

Asunto(s)

Hemorragia Cerebral/genética , Recién Nacido de muy Bajo Peso , Interleucina-6/genética , Regiones Promotoras Genéticas , Sepsis/genética , Sangre/microbiología , Hemorragia Cerebral/diagnóstico , Hemorragia Cerebral/mortalidad , Femenino , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Recién Nacido , Recien Nacido Prematuro , Leucomalacia Periventricular/genética , Leucomalacia Periventricular/mortalidad , Masculino , Sepsis/diagnóstico , Sepsis/mortalidad , Derivación Ventriculoperitoneal

RESUMEN

The duration of the stimulating effect of transplacental transferred thyrotropin-receptor-antibodies (TRAb) is discussed by the example of a 23 years old woman suffering from Graves' disease with a severe hyperthyroidism. She became pregnant six weeks after the diagnosis was obtained and then discontinued her antithyroid medication on her own responsibility. On a check-up in the 20th week of pregnancy, a hyperthyroidism was once more found, leading to a therapy with propylthiouracil, which however, was again interrupted by the patient a few weeks later. In the 32nd week, she gave birth to a male child that already presented with distinct signs of thyrotoxicosis and developed a continuous deterioration of the condition, including a tachycardia with up to 190 beats per minute, fever, tremor and a respiratory disorder. Assay of the newborn serum revealed a severe hyperthyroidism. The TRAb level was 180 U/l (normal range < 15). A therapy with propranolol and prednisolone was initiated, leading to a significant improvement of the general condition. Nevertheless, after 12 days, there was still no notable decrease of the hormone levels. Therefore an antithyroid medication was started, which caused normal thyroid hormone levels within 9 days. However, after the therapy was stopped, a hyperthyroidism was again observed within one week, requiring another, low-dose antithyroid medication, which was administered for 26 days. After this period, the TRAb level was down to 25 U/l and no more hyperthyroidism was found. The biological half-life of the TRAb was 20 days in our case.

Asunto(s)

Autoanticuerpos/sangre , Enfermedad de Graves/inmunología , Hipertiroidismo/etiología , Recien Nacido Prematuro , Intercambio Materno-Fetal , Complicaciones del Embarazo/inmunología , Receptores de Tirotropina/inmunología , Tirotoxicosis/etiología , Adulto , Antiarrítmicos/uso terapéutico , Antitiroideos/uso terapéutico , Carbimazol/uso terapéutico , Cardiotónicos/uso terapéutico , Dobutamina/uso terapéutico , Femenino , Enfermedad de Graves/sangre , Humanos , Hipertiroidismo/tratamiento farmacológico , Recién Nacido , Masculino , Prednisolona/uso terapéutico , Embarazo , Complicaciones del Embarazo/sangre , Efectos Tardíos de la Exposición Prenatal , Propranolol/uso terapéutico , Taquicardia/tratamiento farmacológico , Taquicardia/etiología , Tirotoxicosis/tratamiento farmacológico

RESUMEN

Two children with ring chromosome 14 are described. Both children have only few phenotypical features suggestive of a chromosome abnormality. Both have, however, epilepsy which is typical for the ring chromosome 14 syndrome. Chromosome examination is recommended in children with mental retardation and epilepsy which is refractory to treatment.

Asunto(s)

Cromosomas Humanos Par 14 , Cromosomas en Anillo , Anomalías Múltiples/genética , Preescolar , Epilepsia/genética , Humanos , Lactante , Cariotipificación , Masculino , Síndrome

RESUMEN

We report on two half-brothers with the FG syndrome which is an X-linked recessive multiple congenital anomalies/mental retardation (MCA/MR) syndrome. Both patients show postnatal short stature and an altogether characteristic face consisting of droopy appearance, macrocephaly, frontal upsweep, hypertelorism, full lower lip, retrognathia, and dysmorphic ears. Moreover, since early infancy both have a tendency towards constipation, their muscle tone is low and psychomotor development is moderately retarded. Minor expression of this syndrome in the patients' mother and her two mentally retarded brothers give additional support to the X-linked nature of the condition. On the basis of the pertinent literature, a concise description of this MCA/MR syndrome with variable expression is given. Diagnostic evaluation of dysmorphic male patients with psychomotor retardation should always consider the FG syndrome which has been known since 1974 but still is inadequately recognised in the German literature.

Asunto(s)

Anomalías Múltiples/genética , Discapacidad Intelectual/genética , Aberraciones Cromosómicas Sexuales/genética , Cromosoma X , Adulto , Preescolar , Femenino , Humanos , Masculino